SEOUL -- South Korean drugmaker Celltrion will build its first overseas factory in China, the company said Tuesday, as it prepares to start contract manufacturing in the country.
Construction in the central Chinese city of Wuhan begins during the first half of this year, with at least 600 billion won ($514 million) to be invested by 2025.
